HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-MAR-20 6W9I TITLE SUBSTITUTED BENZYLOXYTRICYCLIC COMPOUNDS AS RETINOIC ACID-RELATED TITLE 2 ORPHAN RECEPTOR GAMMA T AGONISTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA, STEROID RECEPTOR COACTIVATOR 1 COMPND 3 FUSION; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA, SRC-1; COMPND 8 EC: 2.3.1.48; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG, NCOA1, BHLHE74, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RORGT, NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVE AGONIST, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, TRANSFE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 3 18-OCT-23 6W9I 1 REMARK REVDAT 2 13-MAY-20 6W9I 1 JRNL REVDAT 1 29-APR-20 6W9I 0 JRNL AUTH L.S.HARIKRISHNAN,P.GILL,M.G.KAMAU,L.Y.QIN,Z.RUAN,D.O'MALLEY, JRNL AUTH 2 T.HUYNH,S.STACHURA,C.L.CAVALLARO,Z.LU,J.J-W DUAN, JRNL AUTH 3 C.A.WEIGELT,J.S.SACK,M.RUZANOV,J.KHAN,M.GURURAJAN,J.J.WONG, JRNL AUTH 4 Y.HUANG,M.YARDE,Z.LI,C.CHEN,H.SUN,V.BOROWSKI,A.MURTAZA, JRNL AUTH 5 B.E.FINK JRNL TITL SUBSTITUTED BENZYLOXYTRICYCLIC COMPOUNDS AS RETINOIC JRNL TITL 2 ACID-RELATED ORPHAN RECEPTOR GAMMA T (ROR GAMMA T) AGONISTS. JRNL REF BIOORG.MED.CHEM.LETT. V. 30 27204 2020 JRNL REFN ESSN 1464-3405 JRNL PMID 32334911 JRNL DOI 10.1016/J.BMCL.2020.127204 REMARK 2 REMARK 2 RESOLUTION. 1.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (6-FEB-2020) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 72.8 REMARK 3 NUMBER OF REFLECTIONS : 29073 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1471 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.61 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.71 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 20.00 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 559 REMARK 3 BIN R VALUE (WORKING SET) : 0.2546 REMARK 3 BIN FREE R VALUE : 0.2999 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.95 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 23 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2038 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 222 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.89 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.19350 REMARK 3 B22 (A**2) : 0.19350 REMARK 3 B33 (A**2) : -0.38690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.127 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.124 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.118 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2150 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2926 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 763 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 392 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2127 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 266 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2063 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.84 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.85 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.08 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6W9I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1000247854. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29073 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.608 REMARK 200 RESOLUTION RANGE LOW (A) : 57.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 72.9 REMARK 200 DATA REDUNDANCY : 12.40 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 15.1 REMARK 200 DATA REDUNDANCY IN SHELL : 9.70 REMARK 200 R MERGE FOR SHELL (I) : 1.33500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 6VQF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 8-10MG/ML, WITH 0.2M MGCL2, REMARK 280 22% PEG3350, 0.1M BIS-TRIS PH 5.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.58100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 30.84050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 30.84050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 38.79050 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 30.84050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 30.84050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 116.37150 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 30.84050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 30.84050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 38.79050 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 30.84050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 30.84050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 116.37150 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 77.58100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 244 REMARK 465 GLY A 245 REMARK 465 SER A 246 REMARK 465 SER A 247 REMARK 465 HIS A 248 REMARK 465 HIS A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 SER A 254 REMARK 465 SER A 255 REMARK 465 GLY A 256 REMARK 465 LEU A 257 REMARK 465 VAL A 258 REMARK 465 PRO A 259 REMARK 465 ARG A 260 REMARK 465 GLY A 261 REMARK 465 SER A 262 REMARK 465 HIS A 263 REMARK 465 THR A 508 REMARK 465 SER A 509 REMARK 465 GLY A 510 REMARK 465 GLY A 511 REMARK 465 SER A 512 REMARK 465 GLY A 513 REMARK 465 GLY A 514 REMARK 465 LEU A 515 REMARK 465 THR A 516 REMARK 465 GLU A 517 REMARK 465 ARG A 518 REMARK 465 HIS A 519 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 302 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 LYS A 438 CG CD CE NZ REMARK 470 LYS A 520 CD CE NZ REMARK 470 HIS A 523 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 524 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 527 CG CD OE1 NE2 REMARK 470 GLU A 528 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 265 111.01 65.43 REMARK 500 CYS A 393 57.58 -141.47 REMARK 500 GLU A 435 66.17 -116.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Z7D A 4000 DBREF 6W9I A 265 508 UNP P51449 RORG_HUMAN 265 508 DBREF 6W9I A 515 528 UNP Q15788 NCOA1_HUMAN 683 696 SEQADV 6W9I MET A 244 UNP P51449 INITIATING METHIONINE SEQADV 6W9I GLY A 245 UNP P51449 EXPRESSION TAG SEQADV 6W9I SER A 246 UNP P51449 EXPRESSION TAG SEQADV 6W9I SER A 247 UNP P51449 EXPRESSION TAG SEQADV 6W9I HIS A 248 UNP P51449 EXPRESSION TAG SEQADV 6W9I HIS A 249 UNP P51449 EXPRESSION TAG SEQADV 6W9I HIS A 250 UNP P51449 EXPRESSION TAG SEQADV 6W9I HIS A 251 UNP P51449 EXPRESSION TAG SEQADV 6W9I HIS A 252 UNP P51449 EXPRESSION TAG SEQADV 6W9I HIS A 253 UNP P51449 EXPRESSION TAG SEQADV 6W9I SER A 254 UNP P51449 EXPRESSION TAG SEQADV 6W9I SER A 255 UNP P51449 EXPRESSION TAG SEQADV 6W9I GLY A 256 UNP P51449 EXPRESSION TAG SEQADV 6W9I LEU A 257 UNP P51449 EXPRESSION TAG SEQADV 6W9I VAL A 258 UNP P51449 EXPRESSION TAG SEQADV 6W9I PRO A 259 UNP P51449 EXPRESSION TAG SEQADV 6W9I ARG A 260 UNP P51449 EXPRESSION TAG SEQADV 6W9I GLY A 261 UNP P51449 EXPRESSION TAG SEQADV 6W9I SER A 262 UNP P51449 EXPRESSION TAG SEQADV 6W9I HIS A 263 UNP P51449 EXPRESSION TAG SEQADV 6W9I MET A 264 UNP P51449 EXPRESSION TAG SEQADV 6W9I SER A 509 UNP P51449 LINKER SEQADV 6W9I GLY A 510 UNP P51449 LINKER SEQADV 6W9I GLY A 511 UNP P51449 LINKER SEQADV 6W9I SER A 512 UNP P51449 LINKER SEQADV 6W9I GLY A 513 UNP P51449 LINKER SEQADV 6W9I GLY A 514 UNP P51449 LINKER SEQRES 1 A 285 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 285 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 A 285 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 A 285 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 A 285 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 A 285 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 A 285 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 A 285 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 A 285 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 A 285 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 A 285 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 A 285 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 A 285 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 A 285 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 A 285 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 A 285 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 A 285 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 A 285 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 A 285 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 A 285 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 A 285 GLU LEU PHE SER THR SER GLY GLY SER GLY GLY LEU THR SEQRES 22 A 285 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU HET Z7D A4000 52 HETNAM Z7D 1-(BENZYLOXY)-4-{1-[(4-FLUOROPHENYL) HETNAM 2 Z7D SULFONYL]CYCLOPENTYL}BENZENE FORMUL 2 Z7D C24 H23 F O3 S FORMUL 3 HOH *222(H2 O) HELIX 1 AA1 SER A 266 THR A 284 1 19 HELIX 2 AA2 ARG A 288 ARG A 294 1 7 HELIX 3 AA3 SER A 301 ARG A 310 1 10 HELIX 4 AA4 SER A 312 LEU A 338 1 27 HELIX 5 AA5 CYS A 345 MET A 365 1 21 HELIX 6 AA6 GLY A 384 GLY A 392 5 9 HELIX 7 AA7 CYS A 393 ALA A 409 1 17 HELIX 8 AA8 SER A 413 ILE A 426 1 14 HELIX 9 AA9 GLU A 435 THR A 457 1 23 HELIX 10 AB1 ARG A 459 LEU A 466 5 8 HELIX 11 AB2 PRO A 468 HIS A 490 1 23 HELIX 12 AB3 HIS A 490 PHE A 498 1 9 HELIX 13 AB4 PRO A 499 SER A 507 1 9 HELIX 14 AB5 ILE A 521 GLU A 528 1 8 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SITE 1 AC1 9 TRP A 317 MET A 358 VAL A 361 PHE A 378 SITE 2 AC1 9 ILE A 397 ILE A 400 PHE A 401 HIS A 479 SITE 3 AC1 9 HOH A4125 CRYST1 61.681 61.681 155.162 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016212 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016212 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006445 0.00000